Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has filed a statement of deviation or variation with the Exchange as required under Regulation 32 of the SEBI Listing Obligations and Disclosure Requirements (LODR) rules. This regulation applies when a company raises money through a public issue, rights issue, or preferential allotment and then uses those funds in a manner different from what was originally disclosed to shareholders. The filing indicates that there is some difference between the stated purpose of fund usage and the actual deployment. Specific details of the deviation amount, the original objective, and the revised use of proceeds would be available in the full filing submitted to the Exchange.
Investors should review the full Reg. 32 filing to understand how the company has diverted or varied the use of funds originally raised, as this can signal changes in business priorities or cash flow management. Minor deviations are routine, but significant variations may affect investor confidence and warrant closer scrutiny of the company's capital allocation decisions.